Oral Submucous Fibrosis and Its Relation with Stromal Vascularity: A Systematic Review



Abstract Views
448

Downloads
449

Citations

Share

##plugins.themes.bootstrap3.article.sidebar##

Submitted Feb 4, 2020
Published Mar 14, 2020
10.24018/ejmed.2020.2.2.162

Abstract viewed = 448 times

Table of Contents

##plugins.themes.bootstrap3.article.main##

Oral submucous fibrosis (OSMF) is a chronic progressive, scarring disease affecting oral, oropharyngeal, and sometimes the esophageal mucosa. It is characterized by the progressive fibrosis of the submucosal tissue. The pathogenesis of OSMF has been directly related to the habit of chewing areca nut and its commercial preparation, which is widespread in Indian subcontinent and Southeast Asia. Malignant transformation has been reported in 7%–12% cases of OSMF. Histopathological spectrum of OSMF includes the apparent alterations observed in the epithelium and connective tissue. Vascularity in OSMF has always been a matter of debate. The prevailing concept is that epithelial atrophy occurs due to lack of perfusion. The present systemic review was done to evaluate oral submucous fibrosis and its relation with stromal vascularity.

Keywords: Oral submucous fibrosis, vascularity, epithelial atrophy

Downloads

Download data is not yet available.

References

  1. Desai SR, Mamatha GS, Khatri MJ, Shetty JS. Immunochemical expression of CD34 for characterization and quantification of mucosal vasculature and its probable role in malignant transformation of atrophic epithelium in oral submucous fibrosis. Oral Oncol. 2010; 46: 553–58.
    DOI  |   Google Scholar
  2. Rajendran R. Oral submucous fibrosis: Etiology, pathogenesis, and future research. Bull World Health Organ. 1994;72: 985–96.
     Google Scholar
  3. Shieh TY, Yang JF. Collagenase activity in oral submucous fibrosis. Proc Natl Sci Counc Repub China B 1992; 16:106-10.
     Google Scholar
  4. Yang SF, Hsieh YS, Tsai CH, Chen YJ, Chang YC. Increased plasminogen activator inhibitor-1/tissue type plasminogen activator ratio in oral submucous fibrosis. Oral Dis 2007; 13:234-8.
    DOI  |   Google Scholar
  5. Rajendran R, Paul S, Mathews PP, Raghul J, Mohanty M. Characterization and quantification of mucosal vasculature in oral submucus fibrosis. Indian J Dent Res. 2005; 16:83–89.
     Google Scholar
  6. Tilakaratne WM, Klinikowski MF, Saku T, Peters TJ, Warnakuasuriya S. Oral submucous fibrosis: Review on etiology and pathogenesis. Oral Oncol 2006; 42:561-8.
     Google Scholar
  7. Lalli A, Tilakaratne WM, Ariyawardana A, Fitchett C, Leigh IM, Hagi-Pavli E, et al. An altered keratinocyte phenotype in oral submucous fibrosis: Correlation of keratin K17 expression with disease severity. J Oral Pathol Med 2008; 37:211-20.
    DOI  |   Google Scholar
  8. Takeda K, Hatamochi A, Ueki H. Increased number of mast cells accompany enhanced collagen synthesis in linear localized scleroderma. Arch Dermatol Res. 1989; 281:288–90.
    DOI  |   Google Scholar
  9. Sabarinath B, Sriram G, Saraswathi TR, Sivapathasundharam B. Immunohistochemical evaluation of mast cells and vascular endothelial proliferation in oral submucous fibrosis. Indian J Dent Res. 2011; 22:116–21.
    DOI  |   Google Scholar
  10. Hannen EJ, Riediger D. The quantification of angiogenesis in relation to metastasis in oral cancer: A review. Int J Oral Maxillofacial Surg. 2004; 33:02–07.
    DOI  |   Google Scholar
  11. Rajalalitha P, Vali S. Molecular pathogenesis of oral submucous fibrosis: A collagen metabolic disorder. J Oral Pathol Med 2005; 34:321-8.
    DOI  |   Google Scholar
  12. Auluck A, Rosin MP, Zhang L, Sumanth KN. Oral submucous fibrosis, a clinically benign but potentially malignant disease: Report of 3 cases and review of the literature. J Can Dent Assoc 2008; 74:735-40.
     Google Scholar
  13. Hazarey VK, Erlewad DM, Mundhe KA, Ughade SN. Oral submucous fibrosis: Study of 1000 cases from central India. J Oral Pathol Med 2007; 36:12-7.
    DOI  |   Google Scholar
  14. Fang CY, Han WN, Fong DY. A morphometric study on the microvessel in oral submucous fibrosis. Hunan Yi Ke Da Xue Xue Bao. 2000; 25:55–7.
     Google Scholar
  15. Singh M, Chaudhary AK, Pandya S, Debnath S, Singh M, Singh PA, et al. Morphometric analysis in potentially malignant head and neck lesions: Oral submucous fibrosis. Asian Pac J Cancer Prev. 2010; 11:257–60.
     Google Scholar
  16. Debnath S, Mitra B, Paul B, Saha TN, Maity A. Morphometric analysis of oral submucous fibrosis and its correlation with histological staging and clinical severity of trismus. Egypt J Ear Nose Throat Allied Sci. 2013; 14:85–90.
    DOI  |   Google Scholar
  17. Rajendran R, Paul S, Mathews PP, Raghul J, Mohanty M. Characterization and quantification of mucosal vasculature in oral submucus fibrosis. Indian J Dent Res. 2005; 16: 83–89.
     Google Scholar
  18. Tilakaratne WM, Klinikowski MF, Saku T, Peters TJ, Warnakulasuriya S. Oral submucous fibrosis: Review on aetiology and pathogenesis. Oral Oncol. 2006; 42: 561–8.
    DOI  |   Google Scholar
  19. Murgod VV, Kale AD, Angadi PV, Hallikerimath S. Morphometric analysis of the mucosal vasculature in oral submucous fibrosis and its comparison with oral squamous cell carcinoma. Journal of oral science.2014; 56:173-78.
    DOI  |   Google Scholar
  20. Tekade SA, Chaudhary MS, Tekade SS, Sarode SC, Wanjari SP, Gadbail AR et al. Early stage oral submucous fibrosis is characterized by increased vascularity as opposed to advanced stages. Journal of clinical and diagnostic research. 2017; 11:92-96.
    DOI  |   Google Scholar
  21. Hande AH, Chaudhary MS, Gawande MN, Gadabali AR, Zade PR, Bajaj S, et al, Oral submucous fibrosis: An enigmatic morpho-insight. J Can Res Ther.2019;15: 463-9.
    DOI  |   Google Scholar